REFERENCES
- Victor FC, Gottlieb AB, Menter A. Chancing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin Dermatol. 2003;21:392–397. [PUBMED], [INFOTRIEVE], [CSA]
- Mckay IA, Leigh IM. Altered keratinocyte growth and differentiation in psoriasis. Clin Dermatol. 1995;13:105–114. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van de Kerkhof PCM. Psoriasis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Edinburg: Mosby; 2003;125–149.
- Krueger JG. The immunological basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol. 2002;46:1–23. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol. 2004;151:3–15. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504–512. [PUBMED], [INFOTRIEVE], [CSA]
- Petzelbauer P, Stingl G, Wolff K, ., et al. Cyclosporin A supresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol. 1991;96:362–369. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Terajima S, Higaki M, Igarashi Y, ., et al. An important role of tumor necrosis factor-α in the induction of adhesion molecules in psoriasis. Arch Dermatol Res. 1998;290:246–252. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oxholm A. Epidermal expression of interleukin-6 and tumor necrosis factor-alpha in normal and inflammatory skin states in humans. APMIS Suppl. 1992;24:1–32. [PUBMED], [INFOTRIEVE], [CSA]
- Nickoloff BJ, Karabin GD, Barker JN, , et al. Cellular localization of interleukin-8, and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 1991;138:129–140. [PUBMED], [INFOTRIEVE], [CSA]
- Prens EP, van Joost T, Hegmans JP, , et al. Effects of cylosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol. 1995;33:947–953. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Das PK, de Boer OJ, Visser A, , et al. Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Derm Venereol Suppl (Stockh). 1994;186:21–22. [CSA]
- Thomson AW, Nalesnik MA, Rilo HR, , et al. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity. 1993;15:215–223. [PUBMED], [INFOTRIEVE], [CSA]
- Gottlieb AB, Infliximab for psoriasis. J Am Acad Dermatol. 2003;49:112–117. [CSA], [CROSSREF]
- Laporte M, Galand P, Fokan D, , et al. Apoptosis in established and healing psoriasis. Dermatology. 2000;200:314–316. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Winterfield LS, Menter A, Gordon K, , et al. Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis. 2005;64 (Suppl 2):ii87–ii90; discussion ii91–ii92, Review. [PUBMED], [CSA], [CROSSREF]
- Tan MH, Lebwohl M. Psoriasis. Drugs Today (Barc). 1998;34:641–647. [CSA], [CROSSREF]
- Mahrle G, Schulze HJ, Farber L, , et al. Low-dose short-term Cyclosporin versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol. 1995;32:78–88. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Won YH, Sauder DN, McKenzie RC. Cyclosporin A inhibits keratinocyte cytokine gene expression. Br J Dermatol. 1994;130:312–319. [PUBMED], [INFOTRIEVE], [CSA]
- Kawashima K, Doi H, Ito Y, , et al. Evaluation of cell death and proliferation in psoriatic epidermis. J Dermatol Sci. 2004;35:207–214. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Elder JT, Hammerberg C, Cooper KD, , et al. Cyclosporin A Rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes. J Invest Dermatol. 1993;101:761–766. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Faerber L, Braeutigam M, Weidinger G, , et al. Cyclosporin in servere psoriasis: results of a meta-analysis in 579 patients. Am J Clin Dermatol. 2001;2:41–47. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Timonen P, Friend D, Abeywickrama K, , et al. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. Br J Dermatol. 1990;36:33–39. [CSA]
- Ellis CN, Fradin MS, Messana JM, et al. Cyclosporin for plaque-type psoriasis: results of multidose, double-blind trial. N Engl J Med. 1991;324:277–284. [PUBMED], [INFOTRIEVE], [CSA]
- Laburte C, Grossman R, Abi-Rached J, , et al. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis. Br J Dermatol. 1994;130:366–375. [PUBMED], [INFOTRIEVE], [CSA]
- Gearing AJ, Fincham NJ, Bird CR, , et al. Cytokines in skin lesions of psoriasis. Cytokine. 1990;2:68–75. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nickoloff BJ, Karabin GD, Barker JN, , et al. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 1991;138:129–140. [PUBMED], [INFOTRIEVE], [CSA]
- Gamble JR, Harlan JM, Klebanoff SJ, , et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA. 1985;82:8667–8671. [PUBMED], [INFOTRIEVE], [CSA]
- Uyemura K, Yamamura M, Fivenson DF, , et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol. 1993;101:701–705. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pober JS, Gimbrone MA Jr, Lapierre LA, , et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986;137:1893–1896. [PUBMED], [INFOTRIEVE], [CSA]
- Jahn H, Nielsen EH, Elberg JJ, , et al. Ultrastructure of psoriatic epidermis. APMIS. 1988;96:723–731. [PUBMED], [INFOTRIEVE], [CSA]
- Mete UO, Denli YG, Ozbilgin MK, , et al. Electron microscopy of psoriatic skin before and after psoralen/ultraviolet A treatment. Cutis. 1996;58:83–86. [PUBMED], [INFOTRIEVE], [CSA]
- Tsuji T, Cox AJ. Ultrastructural studies of nuclei and nucleoli in psoriatic epidermis, compared to with those in normal epidermis. J Invest Dermatol. 1977;69:205–210. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vaccaro M, Pergolizzi S, Mondello MR, , et al. The dermoepidermal junction in psoriatic skin as revealed by scanning electron microscopy. Arch Dermatol Res. 1999;291:396–399. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mochella SL, Hurley HJ. Dermatology, ed 3. Philadelphia: WB Saunders; 1992:618.
- Mercer EH, Maibach HI. Intercellular adhesion and surface coats of epidermal cells in psoriasis. J Invest Dermatol. 1968;51:215–221. [PUBMED], [INFOTRIEVE], [CSA]
- Boehncke WH, Wortmann S, Kaufmann R, , et al. A subset of macrophages located along basement membrane (lining cells) is characteristic histopathological feature of psoriasis. Am J Dermatopathol. 1995;17:139–144. [PUBMED], [INFOTRIEVE], [CSA]
- Heng MC, Kloss SG, Kuehn CS, , et al. Significance and pathogenesis of basal keratinocyte herniations in psoriasis. J Invest Dermatol. 1986;87:362–366. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Magaudda L, Mondello MR, Vaccaro M, , et al. Changes in the distrubution of actin-associated proteins in psoriatic keratinocytes: immunohistochemical study using confocol electron microscopy. Arch Dermatol Res. 1997;289:378–383. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mondello MR, Califano L, Cannavo SP, , et al. Psoriasis and cyclosporin: immunohistochemical aspects of the basement membrane. Acta Derm Venereol Suppl (Stockh). 1994;186:96–98. [CSA]
- Mussi A, Bonifati C, Carducci M, , et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents 1997;11:115–118. [PUBMED], [INFOTRIEVE], [CSA]
- Krueger G, Callis K. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis. Arch Dermatol. 2004;140:218–225. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gisondi P, Gubinelli E, Cocuroccia B, , et al. Targeting tumor necrosis factor-alpha in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:175–183. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sligh JE, Ballantyne CM, Rich SS, , et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule-1. Proc Natl Sci USA. 1993;90:8529–8533. [CSA]
- Danno K, Kaji A, Mochizuki T. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments. J Dermatol Sci. 1996;13:49–55. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]